Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

13
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
13
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.6K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

23
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
23
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

23
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
23
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

23
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
23
Antibiotic Selection00:57

Antibiotic Selection

55.1K
Overview
55.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care.

ESMO real world data and digital oncology·2026
Same author

Lenalidomide Plus Dexamethasone as FIRST-Line Therapy in Transplant-Ineligible Patients With Multiple Myeloma: Final Results of the Prospective, Non-Interventional Study FIRST-NIS and Comparison With the FIRST Pivotal Phase III Clinical Trial.

Cancer medicine·2026
Same author

Hydroclimatic instability accelerated the socio-political decline of the Tang Dynasty in northern China.

Communications earth & environment·2025
Same author

Epidemiology and prediction of non-targeted bacteria by the filmarray pneumonia plus panel in culture-positive ventilator-associated pneumonia: a retrospective multicentre analysis.

Annals of intensive care·2025
Same author

Cultural diversity shaped neolithic subsistence in the Carpathian Basin.

Scientific reports·2025
Same author

[Psychosocial traits associated with maintenance of physical activity 12months after a pulmonary rehabilitation program - An exploratory study].

Revue des maladies respiratoires·2025
Same journal

As regards troubled urine flows in males, we're beginning to see the light.

Infectious diseases now·2026
Same journal

Gastrointestinal Cryptococcosis in immunosuppressed patients.

Infectious diseases now·2026
Same journal

DoxyPEP is not just doxycycline: preventing informal antibiotic use through counselling, linkage to care, and stewardship.

Infectious diseases now·2026
Same journal

Antibiotic treatment of male urinary tract infections: scientific rationale behind the 2026 SPILF guidelines.

Infectious diseases now·2026
Same journal

Diagnosis of acute community-acquired bacterial urinary tract infections in adult men.

Infectious diseases now·2026
Same journal

Real-world use of Dalbavancin for vascular graft and Endograft infections.

Infectious diseases now·2026
See all related articles

Related Experiment Video

Updated: Aug 30, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.8K

Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis.

P Danneels1, C Rihet1, C Vannier1

  • 1Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire d'Angers, 4 Rue Larrey, 49100 Angers, France.

Infectious Diseases Now
|August 26, 2022
PubMed
Summary
This summary is machine-generated.

Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae endocarditis is difficult to treat. Cefoxitin, combined with other antibiotics, shows promise as an alternative to carbapenems in challenging cases.

Area of Science:

  • Infectious Diseases
  • Internal Medicine
  • Pharmacology

Background:

  • Endocarditis caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae presents a significant therapeutic challenge.
Keywords:
Beta-lactamaseCefoxitinEndocarditisEnterobacteriaceae

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.5K
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

12.9K

Related Experiment Videos

Last Updated: Aug 30, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.8K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.5K
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

12.9K
  • Current treatment primarily relies on carbapenems, with limited alternative options documented.